fexofenadine hydrochloride; pseudoephedrine hydrochloride · Chattem Sanofi · NDA 021704
Allegra-D 24 Hour Allergy And Congestion
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 216792, L Perrigo Co · 021704-002Approved 7 Oct 2025Detected 25 Oct 2026Historical import
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021704 · 002 · RLD | tablet, extended release, oral | 180MG;240MG | open |